Viewing Study NCT01401803


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-02-27 @ 4:08 PM
Study NCT ID: NCT01401803
Status: COMPLETED
Last Update Posted: 2013-09-26
First Post: 2011-07-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Brow Lifting With Dysport
Sponsor: Kenneth Beer
Organization:

Study Overview

Official Title: Brow Lifting With Dysport
Status: COMPLETED
Status Verified Date: 2013-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to provide data to assess Dysportâ„¢ injections as a treatment therapy for brow ptosis. This study will assess the outcome of brow lifting with use of Dysport.
Detailed Description: One of the most common reasons that patients present to both dermatologists and plastic surgeons is for brow and lid ptosis. Although some patients that present for these entities require surgery, most will decline to have surgical intervention. Alternative treatments include brow lifting with botulinum toxins.

Brow lifting with botulinum toxins may be performed by injecting the muscles responsible for brow and lid depression. These muscles include: the corrugators, procerus, medical aspect of the frontalis and the depressor component of the orbicularis oculi muscles. By relaxing these muscles, the brow elevators may be able to lift the brow and help both brow and lid ptosis. This trial is unique as it utilizes Dysport to treat an entire anatomic muscle group (the brow depressors) rather than injecting isolated muscles.\_

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: